Omnaris Nasal Spray, Suspension 50Mcg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Omnaris: Nasal spray, suspension (50mcg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Omnaris 50mcg/act Nasal Spray

What is this Medicine?

CICLESONIDE (sye KLES oh nide) is a corticosteroid. It is used to treat nasal allergy symptoms like sneezing, itching, and runny or stuffy nose. This medicine will not treat an infection.

CVS Pharmacy Patient Statistics for Omnaris: Nasal spray, suspension(50mcg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Omnaris 50mcg/actuation Nasal Spray

NDC: 634020701
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Allergic Rhinitis

Storage Information
Do not freeze
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Omnaris 50mcg/actuation Nasal Spray

Reported Side Effects for Omnaris 50mcg/actuation Nasal Spray

Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Yeast Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Allergic Skin Reaction Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Cough Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Nasal Septum Perforation Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Infection Incidence:
>2.0%*
Severity: MILD
Onset: DELAYED
Flu Incidence:
>2.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
3.0-11.0%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
3.0-10.5%*
Severity: MILD
Onset: DELAYED
Sinus Infection Incidence:
3.1-5.5%*
Severity: MILD
Onset: DELAYED
Nasal Irritation Incidence:
3.2-5.7%*
Severity: MILD
Onset: EARLY
Nose Bleed Incidence:
4.9-6.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Omnaris

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5